dithiothreitol has been researched along with bortezomib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farah, M; Webster, JM; Wojcikiewicz, RJ; Xu, Q | 1 |
1 other study(ies) available for dithiothreitol and bortezomib
Article | Year |
---|---|
Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Calcium Channels; Cell Line; Cells, Cultured; Dithiothreitol; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; HeLa Cells; Histones; Humans; I-kappa B Proteins; Inositol 1,4,5-Trisphosphate Receptors; Mice; NF-KappaB Inhibitor alpha; Protease Inhibitors; Proteasome Inhibitors; Protein Binding; Pyrazines; Receptors, Cytoplasmic and Nuclear; Time Factors; Ubiquitin; Ubiquitin-Conjugating Enzymes | 2004 |